Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Shortages Remove Shortages filter Direct healthcare professional communication (6) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (5) Apply Yes filter

Authorisation status

Authorised (373) Apply Authorised filter Refused (14) Apply Refused filter Withdrawn (47) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (10) Apply Positive filter

Application type

Initial authorisation (8) Apply Initial authorisation filter Post-authorisation (2) Apply Post-authorisation filter

Withdrawal type

Initial authorisation (62) Apply Initial authorisation filter Post-authorisation (3) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (6) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (67) Apply PM: decision on the application for modification of an agreed PIP filter W: decision granting a waiver in all age groups for all conditions or indications (17) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (10) Apply Yes filter

Compliance procedure number

Orphan disease / condition

Orphan decision number

Orphan designation status

Positive (212) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Referral name

Referral status

European Commission final decision (4) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 31 referrals (3) Apply Article 31 referrals filter Article 20 procedures (2) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (4) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (3) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (2) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (658) Apply Additional monitoring filter Biosimilar (78) Apply Biosimilar filter Conditional approval (82) Apply Conditional approval filter Exceptional circumstances (68) Apply Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

818 results

Remove all filtersRemove all filters

Medicine Shortages Remove Shortages filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Orphan medicine Remove Orphan medicine filter Generic Remove Generic filter

Sort by

List item

Human medicine European public assessment report (EPAR): Symkevi (updated)

tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018, , , Revision: 7, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Blincyto (updated)

blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015, , , Revision: 11, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Kalydeco (updated)

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , , Revision: 27, Authorised, Last updated: 22/01/2021
List item

Human medicine European public assessment report (EPAR): Wakix (updated)

pitolisant, Narcolepsy
Date of authorisation: 31/03/2016, , , Revision: 9, Authorised, Last updated: 21/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009, , Revision: 12, Authorised, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)

bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019, , Revision: 3, Authorised, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated)

busulfan, Hematopoietic Stem Cell Transplantation
Date of authorisation: 22/09/2014, , Revision: 8, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Grepid (updated)

clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 27/07/2009, , Revision: 21, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Lenvima (updated)

lenvatinib mesilate, Thyroid Neoplasms
Date of authorisation: 28/05/2015, , , Revision: 14, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Kisplyx (updated)

lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016, , , Revision: 12, Authorised, Last updated: 14/01/2021
List item

Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)

zonisamide, Epilepsy
Date of authorisation: 31/03/2016, , Revision: 5, Authorised, Last updated: 14/01/2021
List item

Human medicine European public assessment report (EPAR): Holoclar (updated)

ex vivo expanded autologous human corneal epithelial cells containing stem cells, Stem Cell Transplantation, Corneal Diseases
Date of authorisation: 17/02/2015, , , , Revision: 7, Authorised, Last updated: 14/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009, , Revision: 15, Authorised, Last updated: 13/01/2021
List item

Human medicine European public assessment report (EPAR): Daurismo (updated)

Glasdegib maleate, Leukemia, Myeloid, Acute
Date of authorisation: 26/06/2020, , , Revision: 1, Authorised, Last updated: 08/01/2021
List item

Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)

daptomycin, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 22/03/2017, , Revision: 9, Authorised, Last updated: 08/01/2021
List item

Human medicine European public assessment report (EPAR): Ninlaro (updated)

ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016, , , , Revision: 8, Authorised, Last updated: 08/01/2021
List item

Veterinary medicine European public assessment report (EPAR): Meloxidolor (updated)

meloxicam, Horses, Dogs, Cattle, Cats, Pigs
Date of authorisation: 22/04/2013, , Revision: 8, Authorised, Last updated: 07/01/2021
List item

Human medicine European public assessment report (EPAR): Luxturna (updated)

voretigene neparvovec, Leber Congenital Amaurosis, Retinitis Pigmentosa
Date of authorisation: 22/11/2018, , , Revision: 3, Authorised, Last updated: 05/01/2021
List item

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

telmisartan, Hypertension
Date of authorisation: 29/09/2010, , Revision: 10, Authorised, Last updated: 05/01/2021
List item

Human medicine European public assessment report (EPAR): Ofev (updated)

nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015, , Revision: 16, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)

clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009, , Revision: 15, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Alofisel (updated)

darvadstrocel, Rectal Fistula
Date of authorisation: 23/03/2018, , , Revision: 6, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Hemlibra

Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018, , , Revision: 7, Authorised, Last updated: 22/12/2020
List item

Human medicine European public assessment report (EPAR): Zytiga

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 05/09/2011, , Revision: 23, Authorised, Last updated: 21/12/2020
List item

Human medicine European public assessment report (EPAR): Mylotarg

gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of authorisation: 19/04/2018, , , Revision: 7, Authorised, Last updated: 21/12/2020

Load more

818 results

Human medicine European public assessment report (EPAR): Symkevi (updated)

Human medicine European public assessment report (EPAR): Blincyto (updated)

Human medicine European public assessment report (EPAR): Kalydeco (updated)

Human medicine European public assessment report (EPAR): Wakix (updated)

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated)

Human medicine European public assessment report (EPAR): Grepid (updated)

Human medicine European public assessment report (EPAR): Lenvima (updated)

Human medicine European public assessment report (EPAR): Kisplyx (updated)

Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)

Human medicine European public assessment report (EPAR): Holoclar (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)

Human medicine European public assessment report (EPAR): Daurismo (updated)

Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)

Human medicine European public assessment report (EPAR): Ninlaro (updated)

Veterinary medicine European public assessment report (EPAR): Meloxidolor (updated)

Human medicine European public assessment report (EPAR): Luxturna (updated)

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

Human medicine European public assessment report (EPAR): Ofev (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)

Human medicine European public assessment report (EPAR): Alofisel (updated)

Human medicine European public assessment report (EPAR): Hemlibra

Human medicine European public assessment report (EPAR): Zytiga

Human medicine European public assessment report (EPAR): Mylotarg